Effectiveness of wheat soya blend supplementation during pregnancy and lactation on pregnancy outcomes and nutritional status of their infants at 6 months of age in Thatta and Sujawal districts of Sindh, Pakistan: a cluster randomized-controlled trial
Purpose We aimed to assess the effectiveness of wheat soya blend plus (WSBP) provided during pregnancy and lactation on weight gain during pregnancy, reduction of low birthweight (LBW), and improvement in nutritional status in infants at 6 months of age in Thatta and Sujawal districts of Sindh, Paki...
Gespeichert in:
Veröffentlicht in: | European journal of nutrition 2021-03, Vol.60 (2), p.781-789 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Purpose
We aimed to assess the effectiveness of wheat soya blend plus (WSBP) provided during pregnancy and lactation on weight gain during pregnancy, reduction of low birthweight (LBW), and improvement in nutritional status in infants at 6 months of age in Thatta and Sujawal districts of Sindh, Pakistan.
Methods
A cluster randomized-controlled trial was conducted in Thatta and Sujawal districts in Pakistan from August 2014 to December 2016. A total of 2030 pregnant women were enrolled in the study. These women and their infants were followed during pregnancy and first 6 months of life. Pregnant women received a monthly ration of 5 kg (i.e., 165 g/day) of WSB + during pregnancy and the first 6 months of their lactation period.
Results
There was no difference in weight gain during pregnancy between the intervention and control groups (
n
= 496, 326.7 g/week 95% CI 315.2–338.1 vs. (
n
= 507, 306.9 g/week, 95% CI 279.9–333.9
P
= 0.192), after adjustment with different factors. The reduction in the prevalence of LBW was not different between intervention and control groups (
n
= 325, 34.0%, 95% CI 31.7–36.4, vs. (
n
= 127, 34.3%, 95% CI 27.2–41.5,
P
= 0.932). Significant reductions in risk of stunting (
n
= 1319 RR 0.85, 95% CI 0.73–0.99,
P
= 0.041), wasting (
n
= 1330 RR 0.77, 95% CI 0.65–0.91,
P
= 0.003), and underweight (
n
= 1295 RR 0.77, 95% CI 0.69–0.87,
P
|
---|---|
ISSN: | 1436-6207 1436-6215 |
DOI: | 10.1007/s00394-020-02276-3 |